AstraZeneca said on Thursday it would build a cell therapy manufacturing and supply base and an innovation centre in Shanghai, aiming to become the first global drugmaker with end-to-end cell ... ( read original story ...)
CGI Shanghai’s sustained outreach since January 2026 deepens cooperation with local governments, key economic sectors and global partners
These efforts by CGI Shanghai have showcased Indias rich heritage, innovation and global outlook while promoting deeper mutual understanding and mutually beneficial partnerships across eastern China. ( read original story ...)
China’s shipping digital push hits regulatory wall as rules lag behind technology
Experts say vessels are ready to become digital assets, but standards and cross-border rules remain the real bottleneck ... ( read original story ...)
Shanghai stock benchmark briefly slips as ME conflict escalates
The Shanghai Composite index briefly slipped past the 4,000 floor for the first time since January, before closing down 1.4 percent at 4,006.55. The blue-chip CSI300 index dipped 1.6 percent. ( read original story ...)
China’s Bank of Ningbo readies digital yuan business as Beijing expands e-CNY
SHANGHAI/BEIJING, March 20 (Reuters) - China's Bank of Ningbo said it is inviting suppliers to help build a system to handle the digital yuan, in a sign that the country's central bank may soon hand ... ( read original story ...)
Shanghai certifies 30 overseas offices amid China’s investment sales pitch
The city welcomed a batch of new regional headquarters and R&D centres this week, as China continues its campaign to win back overseas capital. ( read original story ...)
AstraZeneca says it will build cell therapy base, innovation centre in Shanghai
SHANGHAI, March 19 (Reuters) - AstraZeneca said on Thursday it will build a cell therapy manufacturing and supply base and an innovation centre in Shanghai, aiming to become the first global drugmaker ... ( read original story ...)